z-logo
Premium
Binding and transport of [ 3 H](2 S ,4 R )‐ 4‐methylglutamate, a new ligand for glutamate transporters, demonstrate labeling of EAAT1 in cultured murine astrocytes
Author(s) -
Apricò Karina,
Beart Philip M.,
Crawford Duncan,
O'Shea Ross D.
Publication year - 2004
Publication title -
journal of neuroscience research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.72
H-Index - 160
eISSN - 1097-4547
pISSN - 0360-4012
DOI - 10.1002/jnr.20013
Subject(s) - ligand (biochemistry) , glutamate receptor , binding site , biochemistry , transporter , biology , astrocyte , receptor , glycine , microbiology and biotechnology , biophysics , amino acid , endocrinology , gene , central nervous system
Transporters for L ‐glutamate (excitatory amino acid transporters; EAATs), localized to astrocytes, are involved intimately in intermediary metabolism within the brain. Because (2 S ,4 R )‐4‐methylglutamate (4MG) has affinity for glial EAATs, we employed [ 3 H]4MG to define the characteristics of EAATs in cultured murine astrocytes and describe new approaches to analyze EAAT function. Specific binding of [ 3 H]4MG in astrocytic membranes at 4°C represented 90% of total binding. Binding was rapid (apparent t 1/2 ∼7 min) and saturable. Saturation and Scatchard analyses indicated a single binding site (n H = 0.8) with a K d of 6.0 ± 1.5 μM and B max = 9.7 ± 2.9 pmol/mg protein. Binding of [ 3 H]4MG to astrocytic homogenates was Na + ‐dependent and inhibited by K + . Compounds acting at EAATs, such as L ‐glutamate (Glu), D ‐aspartate ( D ‐Asp), L ‐(2 S ,3 S ,4 R )‐2‐(carboxycyclopropyl)glycine and L ‐ trans ‐pyrrolidine‐2,4‐dicarboxylate displaced binding to nonspecific levels. L ‐Serine‐ O ‐sulphate, an EAAT1‐preferring ligand, fully displaced binding of [ 3 H]4MG. In contrast, inhibitors having preferential affinity for EAAT2, L ‐ threo ‐3‐methylglutamate, dihydrokainate, and kainate, were relatively ineffective binding displacers. Agonists and antagonists for Glu receptors failed to significantly inhibit [ 3 H]4MG binding. Studies with [ 3 H] D ‐Asp reinforced evidence that [ 3 H]4MG was binding to EAATs. These data were consistent with Western blot analyses, which indicated abundant expression of EAAT1 but not EAAT2. [ 3 H]4MG was also accumulated rapidly (apparent t 1/2 ∼4 min) into whole astrocytes by a sodium‐ and temperature‐sensitive process (K m of 146 ± 24 μM, V max = 336 ± 27 nmol/mg protein/min), which possessed an EAAT1‐like pharmacologic profile. These findings confirm that 4MG is a substrate for EAAT1 and that the binding assay developed using [ 3 H]4MG can be utilized in various preparations including cultured astrocytes. © 2004 Wiley‐Liss, Inc.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom